Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Salute | Prodotti farmaceutici | 7,48 Mrd € | 45,3x | 8,94 € | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,9% Rialzo | Fai l’upgrade a Pro+ | ||
Grifols | Madrid | Salute | Prodotti farmaceutici | 7,48 Mrd € | 45,3x | 10,90 € | -2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 48,3% Rialzo | Fai l’upgrade a Pro+ | ||
Laborat.Rovi | Madrid | Salute | Prodotti farmaceutici | 3,19 Mrd € | 20,2x | 62,20 € | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Almirall | Madrid | Salute | Prodotti farmaceutici | 1,81 Mrd € | -40,1x | 8,40 € | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,4% Rialzo | Fai l’upgrade a Pro+ | ||
Pharma Mar | Madrid | Salute | Prodotti farmaceutici | 1,29 Mrd € | 2.100x | 73,50 € | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14% Rialzo | Fai l’upgrade a Pro+ | ||
Faes Farma | Madrid | Salute | Prodotti farmaceutici | 1,08 Mrd € | 11,1x | 3,47 € | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,1% Rialzo | Fai l’upgrade a Pro+ | ||
Clinica Baviera SA | Madrid | Salute | Fornitori e servizi sanitari | 570,58 Mln € | 14,8x | 0,69 | 35 € | -2,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Natac Natural Ingredients | Madrid | Salute | Prodotti farmaceutici | 269,58 Mln € | -39,2x | 0,62 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Atrys Health | Madrid | Salute | Fornitori e servizi sanitari | 243,76 Mln € | -6,3x | -0,72 | 3,27 € | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Laboratorio Reig Jofre | Madrid | Salute | Prodotti farmaceutici | 227,37 Mln € | 23,9x | 2,84 € | -2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 41,4% Rialzo | Fai l’upgrade a Pro+ | ||
Prim SA | Madrid | Salute | Attrezzature e forniture medicali | 169,48 Mln € | 14,8x | 0,88 | 9,96 € | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Oryzon Genomics | Madrid | Salute | Ricerca medica e biotecnologica | 101,59 Mln € | -23,7x | -7,25 | 1,64 € | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pangaea Oncology | Madrid | Salute | Ricerca medica e biotecnologica | 59,62 Mln € | -11,4x | 1,75 € | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Biotechnology Assets | Madrid | Salute | Ricerca medica e biotecnologica | 20,78 Mln € | -6,7x | 0,03 | 0,32 € | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Labiana Health | Madrid | Salute | Prodotti farmaceutici | 15,07 Mln € | -11,7x | -0,15 | 2,18 € | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,1% Rialzo | Fai l’upgrade a Pro+ | |
Substrate Artificial Inteligence | Madrid | Salute | Attrezzature e forniture medicali | 9,94 Mln € | -1x | -0,01 | 0,11 € | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Euroespes S.A. | Madrid | Salute | Fornitori e servizi sanitari | 3,67 Mln € | -3,2x | 0,34 € | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |